Ingelvac Circoflex 50ml

Ingelvac Circoflex 50ml  is for the active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduce PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia. Each dose of 1 ml of inactivated vaccine contains : Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0, maximum RP* 3.75 (*Relative Potency – ELISA test – by comparison with a reference vaccine, Adjuvant : carbomer. Ingelvac Circoflex 50ml Ingelvac Circoflex 50ml .

Ingelvac Circoflex 50ml is for the active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduce PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia. Each dose of 1 ml of inactivated vaccine contains : Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0, maximum RP* 3.75 (*Relative Potency – ELISA test – by comparison with a reference vaccine, Adjuvant : carbomer. Ingelvac Circoflex 50ml Ingelvac Circoflex 50ml

Onset of immunity : by 2 weeks post vaccination

Duration of immunity : at least 17 weeks.

Circoflex is for the active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduce PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia. Each dose of 1 ml of inactivated vaccine contains : Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0, maximum RP* 3.75 (*Relative Potency – ELISA test – by comparison with a reference vaccine, Adjuvant : carbomer.

Onset of immunity : by 2 weeks post vaccination

Duration of immunity : at least 17 weeks.

Legal Category for Ingelvac Circoflex 50ml: POM-V

Dosage: Shake well before use. Single intramuscular injection of one dose (1 ml), irrespective of body weight. Avoid introduction of contamination during use. Vaccines devices should be used in accordance with the device instructions provided by the manufacturer. Avoid multiple broaching.

Gestation Period, lactation and fertility: Do not use during pregnancy and lactation.

Withdrawal Period Ingelvac Circoflex 50ml: Zero days

Contra Indications and special precautions: A mild and transient hyperthermia very commonly occurs on the day of vaccination. On very rare occasions anaphylactic reactions may occur and should be treated symptomatically. Only healthy animals should be vaccinated. Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Boehringer Ingelheim’s Ingelvac MycoFLEX and administered at one injection site.

Packa